Tretinoin
Tretinoin is a pharmaceutical drug with 41 clinical trials. Currently 3 active trials ongoing. Historical success rate of 89.7%.
Success Metrics
Based on 26 completed trials
Phase Distribution
Phase Distribution
10
Early Stage
14
Mid Stage
13
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
86.7%
26 of 30 finished
13.3%
4 ended early
3
trials recruiting
41
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Tretinoin and Arsenic Trioxide With or Without Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia
Tretinoin and Arsenic Trioxide in Treating Patients With Untreated Acute Promyelocytic Leukemia
All-Trans Retinoic Acid (ATRA) and Atezolizumab for the Treatment of Recurrent or Metastatic Non-Small Cell Lung Cancer
Study for Patients With Newly Diagnosed, High-risk Acute Promyelocytic Leukemia
Decitabine and Tretinoin in Treating Patients With Myelodysplastic Syndromes
Clinical Trials (41)
Tretinoin and Arsenic Trioxide With or Without Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia
Tretinoin and Arsenic Trioxide in Treating Patients With Untreated Acute Promyelocytic Leukemia
All-Trans Retinoic Acid (ATRA) and Atezolizumab for the Treatment of Recurrent or Metastatic Non-Small Cell Lung Cancer
Study for Patients With Newly Diagnosed, High-risk Acute Promyelocytic Leukemia
Decitabine and Tretinoin in Treating Patients With Myelodysplastic Syndromes
Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial
Comparison of Quality of Life in Moderate Acne Vulgaris Patients Based on Acne-QoL-INA Using Standard Therapy With and Without Acne Lesions Extraction
A Study of Bomedemstat (IMG-7289/MK-3543) With and Without ATRA, in Participants With Advanced Myeloid Malignancies (IMG-7289-CTP-101/MK-3543-001)
Tretinoin With or Without Fenretinide in Treating Patients With Dysplastic Nevus Syndrome
A Trial of All-trans Retinoic Acid (ATRA) in Advanced Adenoid Cystic Carcinoma
S0521, Combination Chemotherapy With or Without Gemtuzumab Followed By Tretinoin, Mercaptopurine, and Methotrexate or Observation in Treating Patients With Acute Promyelocytic Leukemia
S0535, Gemtuzumab and Combination Chemotherapy in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia
Retinyl Palmitate-loaded Ethosomes in Acne Vulgaris
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Promyelocytic Leukemia
De Novo Lipogenesis of Sebaceous Glands in Acne
Study of TCP-ATRA for Adult Patients With AML and MDS
Bioequivalence Study of Tretinoin Gel 0.05% to Brand Tretinoin Gel
Bioequivalence Study of Generic Tretinoin 0.04% Microsphere Gel, 0.04% Retin-A Micro® and Placebo
Phenylbutyrate and Tretinoin in Treating Patients With Hematologic Cancer
Lithium Carbonate and Tretinoin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 41